Dr. Reddy's Laboratories Ltd. - ADR RDY
Dividend Summary
The next Dr. Reddy's Laboratories Ltd. - ADR dividend is expected to go ex in 9 months and to be paid in 10 months.
The previous Dr. Reddy's Laboratories Ltd. - ADR dividend was 8.34c and it went ex 3 months ago and it was paid 3 months ago.
There is typically 1 dividend per year (excluding specials).
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | Paid | Forecast |
| Type | Final | Final |
| Per share | 8.34c | Sign Up Required |
| Declaration date | 15 May 2026 (Fri) | – |
| Ex-div date | 09 Jul 2026 (Thu) | 08 Jul 2027 (Thu) |
| Pay date | 30 Jul 2026 (Thu) | 29 Jul 2027 (Thu) |
Enter the number of Dr. Reddy's Laboratories Ltd. - ADR shares you hold and we'll calculate your dividend payments:
Sign up for Dr. Reddy's Laboratories Ltd. - ADR and we'll email you the dividend information when they declare.
Add Dr. Reddy's Laboratories Ltd. - ADR to receive free notifications when they declare their dividends.
Your account is set up to receive Dr. Reddy's Laboratories Ltd. - ADR notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| Forecast | Final | – | 05 Jul 2029 | 26 Jul 2029 | USD | Sign up | — | |
| Forecast | Final | – | 06 Jul 2028 | 27 Jul 2028 | USD | Sign up | — | |
| Forecast | Final | – | 08 Jul 2027 | 29 Jul 2027 | USD | Sign up | — | |
| Paid | Final | 15 May 2026 | 09 Jul 2026 | 30 Jul 2026 | USD | 8.35c | 8.34c | 😄 |
| Paid | Final | 30 Jun 2025 | 25 Jul 2025 | 06 Aug 2025 | USD | 9.36c | 9.15c | 😃 |
| Paid | Final | 09 May 2024 | 30 Jul 2024 | 09 Aug 2024 | USD | 47.92c | 47.92c | 😄 |
| Paid | Final | 11 May 2023 | 28 Jul 2023 | 11 Aug 2023 | USD | — | 48.43c | |
| Paid | Final | 24 May 2022 | 08 Jul 2022 | 12 Aug 2022 | USD | — | 37.84c | |
| Paid | Final | 16 Jun 2021 | 08 Jul 2021 | 11 Aug 2021 | USD | — | 38.7c | |
| Paid | Final | 26 Jun 2020 | 10 Jul 2020 | 17 Aug 2020 | USD | — | 33.34c | |
| Paid | Final | – | 12 Jul 2019 | 15 Aug 2019 | USD | — | 28.22c | |
| Paid | Final | – | 13 Jul 2018 | 09 Aug 2018 | USD | — | 29.2c | |
| Paid | Final | – | 13 Jul 2017 | 10 Aug 2017 | USD | — | 31.39c | |
| Paid | Final | – | 14 Jul 2016 | 09 Aug 2016 | USD | — | 29.95c | |
| Paid | Final | 07 Jul 2015 | 08 Jul 2015 | 17 Aug 2015 | USD | — | 31.29c | |
| Paid | Final | 05 Jun 2014 | 01 Aug 2014 | 15 Aug 2014 | USD | — | 29.15c | |
| Paid | Final | 05 Jun 2013 | 10 Jul 2013 | 15 Aug 2013 | USD | — | 26.44c |
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0c | — |
| 2007 | 0.0c | 0% |
| 2008 | 0.0c | 0% |
| 2009 | 0.0c | 0% |
| 2010 | 0.0c | 0% |
| 2011 | 0.0c | 0% |
| 2012 | 26.44c | 100% |
| 2013 | 29.15c | 10.2% |
| 2014 | 31.29c | 7.3% |
| 2015 | 29.95c | -4.3% |
| 2016 | 31.39c | 4.8% |
| 2017 | 29.2c | -7.0% |
| 2018 | 28.22c | -3.4% |
| 2019 | 33.34c | 18.1% |
| 2020 | 38.7c | 16.1% |
| 2021 | 37.84c | -2.2% |
| 2022 | 48.43c | 28.0% |
| 2023 | 47.92c | -1.1% |
| 2024 | 9.15c | -80.9% |
| 2025 | 8.34c | -8.9% |
| 2026 | Sign Up Required | |
| 2027 | Sign Up Required | |
| 2028 | Sign Up Required | |
Dr. Reddy's Laboratories Ltd. Optimized Dividend Chart
- Dividend Yield Today
- 0.6%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 1.0% on 12 May 2026
- 52 Week Low
- 0.6% on 08 July 2026
- Next Ex-Div-Date Countdown
- Sign Up Required
About Dr. Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories Limited is an India-based pharmaceutical company. The Company’s segments include Global Generics, which is engaged in manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients (PSAI), which is engaged in manufacturing and marketing active pharmaceutical ingredients and intermediates for finished pharmaceutical products; Proprietary Products, which focuses on research and development of differentiated formulations and Others, which consists of the Company’s wholly-owned subsidiary, Aurigene Discovery Technologies Limited, which is a discovery stage biotechnology company developing novel and therapies in the fields of oncology and inflammation.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- United States
- Share Price
- $13.07 (yesterday's closing price)
- Shares in Issue
- 835 million
- Market Cap
- $10.9bn
- 0
- Market Indices
- none
